This study investigates pancreatic cancer. It evaluates the effects of low-dose vitamin C combined with herbal medicine on patients with this condition.
The purpose of this study is to assess the impact of this combination on improving quality of life for patients undergoing certain chemotherapy treatments. It evaluates factors like anemia, pain, and overall well-being.
- Who can participate: Adults aged 18 to 80 years with metastatic pancreatic cancer may participate. Key factors include adequate organ function, a minimum hemoglobin level, ECOG performance status of 0-2, and an expected survival of at least 3 months.
- Study details: Participants will receive a combination of vitamin C, Reishi, and Cordyceps with their chemotherapy. A placebo may be used in the study, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand